Cerebras Success Revitalizes Tech IPO Market

While the news reflects a positive atmosphere in the technology IPO market, NVDA stock experienced a 6.3% decline in its latest close, with technical indicators weakening. The RSI stands at 43 in neutral territory, the MACD is below its signal line, and the price is trading below both the 20-day and 50-day moving averages. In the short term, this technical weakness may limit the positive impact of the news. Therefore, due to directional uncertainty, a neutral view appears appropriate.

AMD shares have lost more than 7% in the last 24 hours, with technical indicators pointing to weakening momentum. The RSI stands at 44, near neutral territory, while the MACD is below zero and trading below its signal line. The stock closed below both its 20-day and 50-day moving averages, signaling a negative short-term outlook. Although Cerebras' success has revived the tech IPO market, AMD's current technical structure maintains a bearish trend despite this positive news.

TSM stock fell 5.8% in the last session, with its RSI dropping to 42, approaching short-term oversold territory. The MACD line remains below the signal line and in negative territory, indicating weak momentum. The price is trading below both the 20-day and 50-day moving averages, further weakening the technical outlook. However, the success of Cerebras could revitalize the tech IPO market, potentially increasing interest in the semiconductor sector and indirectly benefiting TSM. While the short-term downtrend may persist, the positive sentiment from the news could create potential for a rebound.

ASML shares experienced an 8.27% decline in the last trading session, with the RSI approaching oversold territory at 37.7. Although the MACD remains in negative territory, it is nearing the signal line, indicating a potential slowdown in bearish momentum. The stock is trading below both the 20-day and 50-day moving averages. While the headline highlights positive developments in the technology IPO market, ASML's current technical weakness makes it difficult to determine a clear short-term direction. Therefore, the short-term outlook is assessed as neutral.